Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Gastric Cancer

Free Subscription Articles published in PLoS One Retrieve available abstracts of 86 articles: HTML format

Single Articles

January 2026
1. HUA NM, Pham VK, Le TTH, Pham SH, et al
   Phytochemical profiling and anticancer activity of the n-butanol fraction from Ardisia villosa extract: Inhibition of gastric cancer cell proliferation via cell cycle arrest and senescence induction.
   PLoS One. 2026;21:e0340458.
   PubMed     Abstract available
   
   
   
2. 
   Retraction: Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition.
   PLoS One. 2026;21:e0340232.
   PubMed    
   
   
   
3. ZHAN Z, Zeng Y, Huang R, Yu J, et al
   Impact of high sodium intake on stomach cancer burden in China: A comprehensive analysis from 1990 to 2021.
   PLoS One. 2026;21:e0334593.
   PubMed     Abstract available
   
   
   
4. LI Y, Zhang L, Wen Z, Wang H, et al
   Integrative genomic analysis reveals DHX58 as a key player in gastric cancer.
   PLoS One. 2026;21:e0341230.
   PubMed     Abstract available
   
   
   
5. 
   Correction: Retraction: Downregulation of FBP1 promotes tumor metastasis and indicates poor prognosis in gastric cancer via regulating epithelial-mesenchymal transition.
   PLoS One. 2026;21:e0341489.
   PubMed     Abstract available
   
   
   
6. TU J, Yu L, Wu K, Gu M, et al
   Mucosal Snare Resection (MSR) in Non-Submucosal Injection Endoscopic Submucosal Excavation (NSI-ESE) for submucosal tumor may not be the preferable choice: A retrospective study.
   PLoS One. 2026;21:e0343335.
   PubMed     Abstract available
   
   
   
7. HU X
   Banana 0.9: An open-source, reproducible medical imaging system for low-resource gastric cancer screening.
   PLoS One. 2026;21:e0339892.
   PubMed     Abstract available
   
   
   
8. LUO S, Yang G, Yuan Y, Zhang Y, et al
   Identification of prognostic genes associated with tolerogenic dendritic cells in gastric cancer based on transcriptomic data.
   PLoS One. 2026;21:e0343688.
   PubMed     Abstract available
   
   
   
9. HUANG M, Chu J, Yu W, Dou L, et al
   Patient-derived organoids predict chemotherapy response of locally advanced gastric cancer.
   PLoS One. 2026;21:e0339416.
   PubMed     Abstract available
   
   
   January 2025
10. LI Z, Cui L, Sun J, Liu W, et al
    Association of preoperative body mass index with postoperative complications and survival for patients with gastric cancer: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0317985.
    PubMed     Abstract available
    
    
    
11. LIU Z, Li H, Deng J, Wu R, et al
    Endoscopic submucosal excavation for gastric muscularis propria tumours less than 10 mm in diameter: What are the risk factors responsible for perforation?
    PLoS One. 2025;20:e0319245.
    PubMed     Abstract available
    
    
    
12. DU P, Zhou J, Liu P, Huang G, et al
    Shortcoming of ypStage staging system: Lack of differentiation for preoperative treatment.
    PLoS One. 2025;20:e0318854.
    PubMed     Abstract available
    
    
    
13. MUSE AH, Almohaimeed A, Alqifari HN, Chesneau C, et al
    Sine-G family of distributions in Bayesian survival modeling: A baseline hazard approach for proportional hazard regression with application to right-censored oncology datasets using R and STAN.
    PLoS One. 2025;20:e0307410.
    PubMed     Abstract available
    
    
    
14. 
    Retraction: GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer.
    PLoS One. 2025;20:e0320614.
    PubMed    
    
    
    
15. HUANG S, Nan Y, Chen G, Ning N, et al
    In vitro experiments and network pharmacology-based investigation of the molecular mechanism of neferine in the treatment of gastric cancer.
    PLoS One. 2025;20:e0318838.
    PubMed     Abstract available
    
    
    
16. ZHAO Y, Han J, Yang R, Wang S, et al
    Evaluating the predictive significance of D-dimer in conjunction with CA724 for the postoperative outcomes in gastric cancer: A retrospective cohort analysis.
    PLoS One. 2025;20:e0320193.
    PubMed     Abstract available
    
    
    
17. FUKUDA K, Mizukami K, Yamaguchi D, Tanaka Y, et al
    Correction: Analysis of clinicopathological factors associate with the visibility of early gastric cancer in endoscopic examination and usefulness of linked color imaging: A multicenter prospective study.
    PLoS One. 2025;20:e0322354.
    PubMed     Abstract available
    
    
    
18. ZHAN Z, Chen B, Zeng Y, Huang R, et al
    Long-term trends and projections of stomach cancer burden in China: Insights from the GBD 2021 study.
    PLoS One. 2025;20:e0320751.
    PubMed     Abstract available
    
    
    
19. PARK J, Kim DY, Suh M, Kim YH, et al
    Assessing gastric cancer risk through longitudinal health check-up data: Insights from a national cohort study in South Korea.
    PLoS One. 2025;20:e0312861.
    PubMed     Abstract available
    
    
    
20. LIU DS, Allan Z, Tie J, Hall K, et al
    Multi-omics evaluation of peritoneal fluid in gastroesophageal cancer (OMEGCA): protocol for a prospective multicentre cohort study to detect occult peritoneal metastases in patients undergoing curative-intent treatment.
    PLoS One. 2025;20:e0318615.
    PubMed     Abstract available
    
    
    
21. 
    Retraction: Casticin potentiates TRAIL-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress.
    PLoS One. 2025;20:e0322907.
    PubMed    
    
    
    
22. SEO JM, Baek SY, Jeong WK, Song KD, et al
    Correction of stomach cancer CT attenuation values for variations due to differences in CT imaging conditions through repeated CT scans.
    PLoS One. 2025;20:e0321085.
    PubMed     Abstract available
    
    
    
23. LI G, Chen J, Chen R, Yu W, et al
    Design, optimization, and ADMET evaluation of S11a-0000168202: A promising LIMK1 inhibitor for gastric cancer treatment.
    PLoS One. 2025;20:e0323699.
    PubMed     Abstract available
    
    
    
24. KO CS, Noh JH, Park YS, Yook JH, et al
    Effect of Helicobacter pylori eradication on remnant stomach neoplasms after curative gastrectomy (HELP-GC): Protocol of a HELP-GC randomized controlled trial.
    PLoS One. 2025;20:e0320903.
    PubMed     Abstract available
    
    
    
25. CHU J, Song H, Fu K, Xiao W, et al
    Utilizing Multi-omics analysis to elucidate the role of mitochondrial gene defects in Gastric cancer progression.
    PLoS One. 2025;20:e0325520.
    PubMed     Abstract available
    
    
    
26. HUANG RJ, Balasubramanian V, Shum MV, Ji HP, et al
    Incidence of non-cardia gastric cancer among commercially-insured individuals aged 18-64 with chronic atrophic gastritis.
    PLoS One. 2025;20:e0315833.
    PubMed     Abstract available
    
    
    
27. LI J, Ma Y, Guo L, Liu J, et al
    Exploring the mechanism of Synechococcus sp. XM-24 in gastric cancer treatment via network pharmacology and molecular docking.
    PLoS One. 2025;20:e0326664.
    PubMed     Abstract available
    
    
    
28. DU C, Liang S, Wang X, Qi Y, et al
    EBV-miR-BART5-5p regulates RORA to promote proliferation and migration of gastric cancer cells.
    PLoS One. 2025;20:e0327323.
    PubMed     Abstract available
    
    
    
29. MIYAZAWA S, Ono H, Yamashita H, Asano D, et al
    Evaluation of therapeutic agent selection based on comprehensive genomic profiling in gastroenteropancreatic neuroendocrine neoplasms.
    PLoS One. 2025;20:e0325727.
    PubMed     Abstract available
    
    
    
30. ZHAO X, Fan M, Ding Y, Pan Y, et al
    Complex intervention based on protective factors to improve resilience for gastric cancer patients: Mixed-methods process evaluation protocol.
    PLoS One. 2025;20:e0329834.
    PubMed     Abstract available
    
    
    
31. YANG X, Chen S, Zhong C, Lai Y, et al
    Trend analysis and projection of the gastric cancer disease burden in Taiwan during 1990-2021: An analysis of the global burden of disease study 2021.
    PLoS One. 2025;20:e0331506.
    PubMed     Abstract available
    
    
    
32. ZHU M, Wang X, Zhang D, Chen A, et al
    Global, regional, and national burdens of five main digestive system cancers in adolescents and young adults from 1990 to 2021 based on the Global Burden of Disease Study 2021: A cross-sectional study.
    PLoS One. 2025;20:e0329377.
    PubMed     Abstract available
    
    
    
33. LEE JO, Kim CY, Lee S, Chung JH, et al
    Multi-cancer analysis of histopathologic MSI screening based on digital histology image.
    PLoS One. 2025;20:e0332034.
    PubMed     Abstract available
    
    
    
34. DU H, Xiang T, Xia Y, Jin Y, et al
    Super-enhancer-associated LINC00963 promotes metastasis of gastric cancer through epithelial-mesenchymal transition.
    PLoS One. 2025;20:e0332396.
    PubMed     Abstract available
    
    
    
35. WU X, Cai L, Liu Y, Wang B, et al
    Multi-omics analysis of parthanatos related molecular subgroup and prognostic model development in stomach adenocarcinoma.
    PLoS One. 2025;20:e0332988.
    PubMed     Abstract available
    
    
    
36. YANG S, Lei H
    Machine learning-driven risk stratification for distant metastasis in gastric cancer: A comparative study of clinical features and composite indices integrated models.
    PLoS One. 2025;20:e0335258.
    PubMed     Abstract available
    
    
    
37. ZHANG T, Guan L, Xie X, Chen J, et al
    Risk of cardiovascular mortality in patients with gastric cancer.
    PLoS One. 2025;20:e0335989.
    PubMed     Abstract available
    
    
    
38. LABOREY M, Lajoinie A, Freilich J, Samalin E, et al
    Methodological approach to optimize a step-by-step deterministic linkage of SNDS data with a clinical database (FREGAT) of gastric/gastroesophageal junction adenocarcinoma in France: Pitfalls and learnings.
    PLoS One. 2025;20:e0333667.
    PubMed     Abstract available
    
    
    
39. FU Y, Cao D, Wu Y, Jia Z, et al
    5-hydroxymethylcytosines from circulating cell-free DNA as noninvasive prognostic markers for gastric cancer.
    PLoS One. 2025;20:e0335654.
    PubMed     Abstract available
    
    
    
40. CHEN Y, Feng P, Lou X, Wang H, et al
    Weifuchun alleviates MNNG-induced chronic atrophic gastritis by improving the gastric and intestinal microbiota homeostasis.
    PLoS One. 2025;20:e0333375.
    PubMed     Abstract available
    
    
    
41. YANG X, Chen S, Zhong C, Lai Y, et al
    Trend analysis and projection of gastric cancer burden linked to high sodium intake in China, Japan, Republic of Korea, and Mongolia (1990-2021): A comprehensive assessment based on the 2021 global burden of disease study.
    PLoS One. 2025;20:e0338030.
    PubMed     Abstract available
    
    
    
42. LI L, Chen H, Zhou F, Shi Y, et al
    Integrated analysis of single-cell and bulk RNA-seq reveals MAGEA3/6-associated immune subtypes and key immune genes in gastric cancer.
    PLoS One. 2025;20:e0338705.
    PubMed     Abstract available
    
    
    January 2024
43. PELC Z, Sedlak K, Mlak R, Chawrylak K, et al
    MalnutritiOn assessment with biOelectrical impedaNce analysis in gastRic cancer patIentS undergoing multimodaltrEatment (MOONRISE)-Study protocol for a single-arm multicenter cross-sectional longitudinal study.
    PLoS One. 2024;19:e0297583.
    PubMed     Abstract available
    
    
    
44. ZHANG H, Cheng X, Guo W, Zheng C, et al
    Metastasis patterns and prognosis in young gastric cancer patients: A propensity score?matched SEER database analysis.
    PLoS One. 2024;19:e0301834.
    PubMed     Abstract available
    
    
    
45. LI N, Yang J, Li X, Shi Y, et al
    Accuracy of artificial intelligence-assisted endoscopy in the diagnosis of gastric intestinal metaplasia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0303421.
    PubMed     Abstract available
    
    
    
46. WU BU, Dong EY, Chen Q, Luong TQ, et al
    Stomach Cancer Prediction Model (SCoPM): An approach to risk stratification in a diverse U.S. population.
    PLoS One. 2024;19:e0303153.
    PubMed     Abstract available
    
    
    
47. PARK H, Miyano S
    Sparse spectral graph analysis and its application to gastric cancer drug resistance-specific molecular interplays identification.
    PLoS One. 2024;19:e0305386.
    PubMed     Abstract available
    
    
    
48. WU Q, Jiang J, Li Z, Ling X, et al
    Long-term survival outcomes of endoscopic therapy vs. surgical resection in patients with cardia gastrointestinal stromal tumor.
    PLoS One. 2024;19:e0306598.
    PubMed     Abstract available
    
    
    
49. OH MJ, Kim SG, Kim J, Na YS, et al
    Clinical outcomes of ablation of gastric dysplasia with argon plasma coagulation.
    PLoS One. 2024;19:e0306934.
    PubMed     Abstract available
    
    
    
50. NAING C, Aung HH, Aye SN, Poovorawan Y, et al
    CagA toxin and risk of Helicobacter pylori-infected gastric phenotype: A meta-analysis of observational studies.
    PLoS One. 2024;19:e0307172.
    PubMed     Abstract available
    
    
    
51. WANG FL, Chang X, Shi Y, Yang T, et al
    beta-Ionone enhances the inhibitory effects of 5-fluorouracil on the proliferation of gastric adenocarcinoma cells by the GSK-3beta signaling pathway.
    PLoS One. 2024;19:e0309014.
    PubMed     Abstract available
    
    
    
52. XUE Z, Li W, Ding H, Pei F, et al
    Virulence gene polymorphisms in Shandong Helicobacter pylori strains and their relevance to gastric cancer.
    PLoS One. 2024;19:e0309844.
    PubMed     Abstract available
    
    
    
53. ASLANI A, Soheili A, Mousavi SE, Ebrahimi A, et al
    Incidence trends of gastric cancer in the United States over 2000-2020: A population-based analysis.
    PLoS One. 2024;19:e0310040.
    PubMed     Abstract available
    
    
    
54. 
    Retraction: Antitumor Activity of Di-n-Butyl-(2,6-Difluorobenzohydroxamato)Tin(IV) against Human Gastric Carcinoma SGC-7901 Cells via G2/M Cell Cycle Arrest and Cell Apoptosis.
    PLoS One. 2024;19:e0312145.
    PubMed    
    
    
    
55. WANG Q, He XC, Geng LX, Jiang SL, et al
    Public awareness of gastric cancer risk factors and screening behaviours in Shijiazhuang, China: A community-based survey.
    PLoS One. 2024;19:e0311491.
    PubMed     Abstract available
    
    
    
56. FUKUDA K, Mizukami K, Yamaguch D, Tanaka Y, et al
    Analysis of clinicopathological factors associate with the visibility of early gastric cancer in endoscopic examination and usefulness of linked color imaging: A multicenter prospective study.
    PLoS One. 2024;19:e0312385.
    PubMed     Abstract available
    
    
    
57. XIONG B, Fan M, Wang Z, Yang X, et al
    Gentiopicroside-Induced gastric cancer necroptosis via the HIF-1 signaling pathway: A study involving molecular docking and experimental validation.
    PLoS One. 2024;19:e0311152.
    PubMed     Abstract available
    
    
    
58. QIAO Z, Zhang Z, Chen J, Yin P, et al
    Influence of lymph node removal on the prognosis of high malignancy potential gastric gastrointestinal stromal tumors: Insights from population-based study.
    PLoS One. 2024;19:e0314504.
    PubMed     Abstract available
    
    
    
59. AISU Y, Oshima N, Hyodo F, Elhelaly AE, et al
    Dual inhibition of oxidative phosphorylation and glycolysis exerts a synergistic antitumor effect on colorectal and gastric cancer by creating energy depletion and preventing metabolic switch.
    PLoS One. 2024;19:e0309700.
    PubMed     Abstract available
    
    
    
60. LI Y, Wang X, Liu X, Li X, et al
    The dysregulation of PARP9 expression is linked to apoptosis and DNA damage in gastric cancer cells.
    PLoS One. 2024;19:e0316476.
    PubMed     Abstract available
    
    
    January 2023
61. ALARIDAH N, F Jarrar R, M Joudeh R, Aljarawen M, et al
    Knowledge and information sources towards Helicobacter pylori in Jordan.
    PLoS One. 2023;18:e0278078.
    PubMed     Abstract available
    
    
    
62. KODAMA M, Mizukami K, Hirashita Y, Okimoto T, et al
    Differences in clinical features and morphology between differentiated and undifferentiated gastric cancer after Helicobacter pylori eradication.
    PLoS One. 2023;18:e0282341.
    PubMed     Abstract available
    
    
    
63. 
    Retraction: MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2.
    PLoS One. 2023;18:e0282977.
    PubMed    
    
    
    
64. 
    Retraction: MicroRNA-219-2-3p Functions as a Tumor Suppressor in Gastric Cancer and Is Regulated by DNA Methylation.
    PLoS One. 2023;18:e0282980.
    PubMed    
    
    
    
65. 
    Retraction: MicroRNA-10a Is Down-Regulated by DNA Methylation and Functions as a Tumor Suppressor in Gastric Cancer Cells.
    PLoS One. 2023;18:e0283120.
    PubMed    
    
    
    
66. 
    Retraction: The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5.
    PLoS One. 2023;18:e0283151.
    PubMed    
    
    
    
67. HU J, Cheng M, Li Y, Shi B, et al
    Ginseng-containing traditional medicine preparations in combination with fluoropyrimidine-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0284398.
    PubMed     Abstract available
    
    
    
68. ZHENG C, Zhang Y, Cao J, Jing X, et al
    Survival benefits of perioperative chemoradiotherapy versus chemotherapy for advanced stage gastric cancer based on directed acyclic graphs.
    PLoS One. 2023;18:e0283854.
    PubMed     Abstract available
    
    
    
69. YOON K, Shin CM, Han K, Jung JH, et al
    Risk of cancer in patients with insomnia: Nationwide retrospective cohort study (2009-2018).
    PLoS One. 2023;18:e0284494.
    PubMed     Abstract available
    
    
    
70. OH SE, Choi MG, Lee JH, Sohn TS, et al
    Meso-jejunal lymph node dissection has a survival benefit in patients with remnant gastric cancer.
    PLoS One. 2023;18:e0285554.
    PubMed     Abstract available
    
    
    
71. RAWICZ-PRUSZYNSKI K, Sedlak K, Pelc Z, Mlak R, et al
    Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer (POLA)-Study protocol for a single-arm prospective observational multicenter study.
    PLoS One. 2023;18:e0285758.
    PubMed     Abstract available
    
    
    
72. SOSSA-ROJAS H, Franco-Maz PG, Zapata-Acevedo C, Gutierrez-Castaneda LD, et al
    Preclinical evaluation of oncolytic potential human rotavirus Wt 1-5 in gastric adenocarcinoma.
    PLoS One. 2023;18:e0285543.
    PubMed     Abstract available
    
    
    
73. 
    Expression of Concern: HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.
    PLoS One. 2023;18:e0286446.
    PubMed    
    
    
    
74. ABE A, Nakayama A, Otsuka Y, Shibata K, et al
    Relationship of preoperative oral hypofunction with prognostic nutritional index in gastric cancer: A case-control retrospective study.
    PLoS One. 2023;18:e0283911.
    PubMed     Abstract available
    
    
    
75. SEO JW, Park KB, Chin HM, Jun KH, et al
    Does Epstein-Barr virus-positive gastric cancer establish a significant relationship with the multiple genes related to gastric carcinogenesis?
    PLoS One. 2023;18:e0283366.
    PubMed     Abstract available
    
    
    
76. HONING J, Keith Tan W, Dieninyte E, O'Donovan M, et al
    Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries.
    PLoS One. 2023;18:e0287587.
    PubMed     Abstract available
    
    
    
77. MARIANI M, Pastorino R, Pires Marafon D, Johnson KC, et al
    Leisure-time physical activity and gastric cancer risk: A pooled study within the Stomach cancer Pooling (StoP) Project.
    PLoS One. 2023;18:e0286958.
    PubMed     Abstract available
    
    
    
78. XU S, Fan Y, Tan Y, Zhang L, et al
    Association between blood lipid levels and risk of gastric cancer: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0288111.
    PubMed     Abstract available
    
    
    
79. HUANG Z, Yang H, Lao J, Deng W, et al
    Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma.
    PLoS One. 2023;18:e0287303.
    PubMed     Abstract available
    
    
    
80. HU Q, Xu J, Ke J, Zhang Z, et al
    S-1 and 5-Fluorouracil-related adverse events in patients with advanced gastric cancer: A meta-analysis.
    PLoS One. 2023;18:e0290003.
    PubMed     Abstract available
    
    
    
81. PARK H, Imoto S, Miyano S
    Comprehensive information-based differential gene regulatory networks analysis (CIdrgn): Application to gastric cancer and chemotherapy-responsive gene network identification.
    PLoS One. 2023;18:e0286044.
    PubMed     Abstract available
    
    
    
82. CHEN Y, Guo Y, Yuan M, Guo S, et al
    USP4 promotes the proliferation and glucose metabolism of gastric cancer cells by upregulating PKM2.
    PLoS One. 2023;18:e0290688.
    PubMed     Abstract available
    
    
    
83. KIATTIWEERASAK A, Bongkotvirawan P, Aumpan N, Yamaoka Y, et al
    Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
    PLoS One. 2023;18:e0291926.
    PubMed     Abstract available
    
    
    
84. MATSUSHITA A, Nakatani E, Shibasaki C, Tanabe S, et al
    Effectiveness of weight-loss prevention with continual nutrition counseling in postoperative outpatients with stage IA and IB gastric cancer.
    PLoS One. 2023;18:e0292920.
    PubMed     Abstract available
    
    
    
85. ZHANG YL, Wang YW, He MJ, Chang JL, et al
    An updated meta-analysis investigating the association between DNMTs gene polymorphism andgastric cancer risk.
    PLoS One. 2023;18:e0293466.
    PubMed     Abstract available
    
    
    
86. ZHANG Y, Qu L, Pan Y, Wu Y, et al
    Predictive value of hepatitis B serological indicators for mortality among cancer survivors and validation in a gastric cancer cohort.
    PLoS One. 2023;18:e0286441.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum